邁博藥業(02181.HK)向濟民可信授出CMAB007中國獨家推廣權

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

邁博藥業(02181.HK)向濟民可信授出CMAB007中國獨家推廣權

阿思達克 04-13 16:58

邁博藥業(02181.HK)宣布，附屬泰州藥業於4月13日與江西濟民可信醫藥訂立CMAB007(奧馬珠單抗)中國市場獨家商業化合作協議，泰州藥業將向其授出CMAB007在中國（包括中國大陸、香港、澳門及台灣地區）的獨家推廣權，而泰州藥業業將繼續擁有CMAB007在推廣服務區域的所有權利及權益，預期有助提升產品的品牌影響力。(gc/u) ~

邁博藥業-B(02181.HK)

Relevant Stocks

邁博藥業-B(02181.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

邁博藥業(02181.HK)向濟民可信授出CMAB007中國獨家推廣權

Services

About Us

Agreement Statement